LENSAR® Reports Adoption of ALLY® System in Multi-Center Ophthalmology Groups

 LENSAR Reports Adoption of ALLY System in Multi-Center Ophthalmology Groups

LENSAR, Inc., a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, has announced that it has completed the installation of multiple ALLY Systems in five private equity-owned (“PE-owned”) ophthalmology groups, including EyeSouth Partners’ network. EyeSouth Partners is one of the largest PE-owned ophthalmic focused, premier networks in the U.S., with 35 practices, 19 surgery centers, and 290 doctors providing medical and surgical eye care services at over 160 locations. EyeSouth’s stated objective is to enable physicians to focus on patient care, while bringing business expertise and financial and operational efficiencies to individual practices in its network.

The Company sees the adoption of the ALLY System by EyeSouth Partners, and by four other PE-owned ophthalmology groups, as a strong sign of appreciation of this recently launched system. Several PE-owned groups, including EyeSouth Partners, have installed ALLY systems in multiple operating rooms within their practices or have indicated an intention to acquire additional systems, which the Company attributes to ALLY’s procedure speed and operational efficiency.

“Private equity-owned ASCs are increasing their share of the cataract surgical market, now representing 14% of all ASC-based procedures in the U.S. These groups provide an exciting new opportunity for the ALLY System, and we believe that investment in the laser for operating rooms is on the rise among PE-owned ASCs, due to the system’s numerous advantages over legacy cataract treatment technologies. We are proud to partner with these groups and pleased that the rapid adoption of ALLY to date has enabled us to bring the system’s benefits to a broader group of surgeons and patients early in the launch cycle,” said Nick Curtis, CEO, LENSAR.

“The ALLY System has brought new, advanced technology to my cataract surgeries that has helped me to be more accurate, which has resulted in better outcomes. The integrated pre-op data and imaging, along with automated features such as cataract density grading and toric IOL alignment tools, has ensured accurate placement of each lens every time,” according to Matthew B. Kaufman, M.D., Managing Partner of North Georgia Eye Associates, an EyeSouth Practice in Gainesville, GA.

“The efficiency of performing a sterile procedure with the ALLY has been a ‘game changer’ for the patients, surgeons, and staff at EyeSouth. I can wholeheartedly state that the ALLY has been faster and more efficient laser, superior to any other laser on the market that I have used,” said Jack M. Chapman, Jr., M.D., Managing Partner of North Georgia Eye Associates and EyeSouth Physician Advisory Board Co-Chair. “The entire procedure has taken between one and two minutes, resulting in a much-improved patient experience compared to the traditional 8 to 10-minute procedure.”

Private Equity-Owned ASCs with At Least One ALLY Installation:

  • US Eye, a network of 20 practices
  • Eye Health America, a network of 8 practices
  • Vision Innovation Partners, a network of 23 practices
  • Eyecare Partners, a network of 46 practices
  • EyeSouth Partners, a network of 35 practices

Read the full press release from LENSAR.

Source: LENSAR

  • <<
  • >>

Comments